opipramol has been researched along with buspirone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Berger, W; Boerner, RJ; Kuhn, U; Mannel, M; Schmidt, U; Sommer, H | 1 |
1 trial(s) available for opipramol and buspirone
| Article | Year |
|---|---|
Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Administration Schedule; Female; Germany; Humans; Kava; Male; Manifest Anxiety Scale; Middle Aged; Opipramol; Phytotherapy; Plant Extracts; Quality of Life; Sleep; Surveys and Questionnaires; Treatment Outcome | 2003 |
1 other study(ies) available for opipramol and buspirone
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |